Ruijun Cai

机构：Jiuquan Iron & Steel (China), Nanfang Hospital, Southern Medical University · ORCID：0009-0009-7036-3126

发表论文 18 篇 · 总被引 260 次 · h-index 7

代表论文

• LncRNA H19 promotes lung cancer proliferation and metastasis by inhibiting miR-200a function (2019 · Molecular and Cellular Biochemistry · 被引 86)
• Mild hypoxia‐induced cardiomyocyte hypertrophy via up‐regulation of HIF‐1α‐mediated TRPC signalling (2011 · Journal of Cellular and Molecular Medicine · 被引 50)
• Development and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung Adenocarcinoma (2022 · Frontiers in Endocrinology · 被引 40)
• Inhibition of angiotensin II-induced contraction of human airway smooth muscle cells by angiotensin-(1-7) via downregulation of the RhoA/ROCK2 signaling pathway (2012 · International Journal of Molecular Medicine · 被引 23)
• Unveiling the Power of Gut Microbiome in Predicting Neoadjuvant Immunochemotherapy Responses in Esophageal Squamous Cell Carcinoma (2024 · Research · 被引 20)
• Different functions of DEPTOR in modulating sensitivity to chemotherapy for esophageal squamous cell carcinoma (2017 · Experimental Cell Research · 被引 12)